WASHINGTON, Nov. 22, 2021 (GLOBE NEWSWIRE) -- According to a new report by Vantage Market Research, the global sickle cell disease market size is expected to reach USD 7.9 billion by 2028, exhibiting a CAGR of 7.81% during the forecast period. Increasing patient pool, advance therapies and increasing R&D activities are some of the factors to bolster the market growth, states Vantage Market Research, in a report, titled “Sickle Cell Disease Market By Treatment Type (Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant), By End User (Hospitals, Diagnostic Centers, Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028.” The market size stood at USD 1.4 billion in 2020.
The report on Sickle Cell Disease Market highlights:
- Assessment of the market
- Premium Insights
- Competitive Landscape
- COVID Impact Analysis
- Historic Data, Estimates and Forecast
- Company Profiles
- Global and Regional Dynamics
Market Overview:
Rising research and development activity to promote high market growth
Rising research and development activity, growing patient pool and a solid pipeline are anticipated to fuel the growth of sickle cell disease market during the projected period. For example, U.S. Food and Drug Administration gave an approval of Voxelotor for sickle cell disease treatment. Similarly, Global Blood Therapeutics has been working on development trials for 10 drugs including Anti-sicking, HbF inducer, Inclacumab, Voxelotor and GF1021601 etc. and it is expected to launch these drugs during projected period, which in turn is expected to drive the high demand of sickle cell disease market.
Get PDF Sample Copy Of This Report To Understand The Structure Of The Complete Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.vantagemarketresearch.com/industry-report/sickle-cell-disease-diagnosis-market-0209/request-sample
Increasing blood transfusion sickle cell treatment fuelling high market demand
Increase in the prevalence of SCD and the high demand for blood transfusion in sickle cell treatment are the factors to drive the market growth. Blood transfusions helps the normal red blood cells supply to increase haemoglobin levels in the body. This in turn improves oxygen delivery and reduces sickle cell blockage in blood vessels. This is the reason for high demand of blood transfusion in the market. In addition, plasma transfusion is also helpful for sickle cell treatment. Thus, it fuels the growth of blood transfusion sickle cell treatment during the forecast period.
Regional Analysis:
North America dominates the sickle cell disease market
North America is forecasted to dominate the sickle cell disease to be the major contributor in the market. This is attributed due to the potential pipeline candidates and improving access to SCD treatment. The major factor to boost the market growth in the region is the strong government support. According to National Centers for Biotechnological Information, NHLBI (National Heart, Lung, and Blood Institute) started a collaborative research to speed up the development of genetic therapies to cure SCD.
List of Prominent Players in the Sickle Cell Disease Market:
| Sr. No. | Companies | HeadquaterS |
| 1. | Novartis AG | Basel, Switzerland |
| 2. | Pfizer Inc. | New York, United States |
| 3. | Global Blood Therapeutics Inc. | South San Francisco, California, United States |
| 4. | Emmaus Medical Inc. | Torrance, California, United States |
| 5. | Eli Lilly & Company | Indianapolis, Indiana, United States |
| 6. | Addmedica Inc. | Paris, France |
| 7. | Medunik USA.Inc. | Rosemont, PA |
| 8. | Bristol Myers Squibb Co. | New York, United States |
| 9. | Baxter Inc. | Deerfield, Illinois, United States |
| 10. | Bluebird Biotechnology | Massachusetts, United States |
| 11. | Glycomimetics Inc. | Rockville, MD |
| 12. | F.Hoffmann-La Roche | Basel, Switzerland |
| 13. | CRISPR Therapeutics | Zug, Switzerland |
Request Pre and Post COVID-19 Impact Analysis on Businesses : https://www.vantagemarketresearch.com/insight/press-release/sickle-cell-disease-diagnosis-market-689085
Recent Developments in the Industry:
1. November 2021: Novartis AG announced new analyses from the two-year positive Phase III JUNIPERA study. This study demonstrates the treatment response of Cosentyx® (secukinumab) in children and adolescents with enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (JPsA) – two categories of juvenile idiopathic arthritis (JIA).
2. October 2021: Novartis AG announced that FDA has approved Scemblix® for the treatment of chronic myeloid leukemia (CML) in two distinct indications.
3. June 2021: Global Blood Therapeutics Inc. announced that the MHRA in the United Kingdom has granted a Promising Innovative Medicine (PIM) designation for Voxelotor for the potential treatment of haemolytic anemia in adults and adolescent patients 12 years of age and older with sickle cell disease (SCD).
This report provides details about prevalence, incidence, distribution of patients, average price of treatment, market & technological trends and new product developments of sickle cell disease market.
| .Report Attribute | Details |
| Base Year | 2020 |
| Historic Years | 2016 – 2019 |
| Forecast Years | 2021 – 2028 |
| Segments Covered |
|
| Quantitative Data - Units | Revenue in USD Million/Billion |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
| Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
| Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert@ https://www.vantagemarketresearch.com/industry-report/sickle-cell-disease-diagnosis-market-0209/inquiry-before-buying
Table of Content –
- Chapter No. 1: Introduction
- Report Scope
- Objectives of the Study
- USP & Key Offerings
- Target Audience
- Vantage Market Research Report Guidance/Walk-through
- Chapter No. 2: Premium Insights
- Market Snapshot
- Top Investment Pockets
- Market Attractiveness Analysis, By Type
- Market Attractiveness Analysis, By End User
- Market Attractiveness Analysis, By Middle East & Africa
- Insights from Primary Respondents
- Chapter No. 3: Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter’s Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
Related Research Reports Studies:
The Global Pain Management Therapy Market was valued at USD 68.36 Billion in 2020 and is projected to reach USD 99.65 Billion by 2028, growing at a CAGR of 4.1% from 2021 to 2028.
The Global Cord Blood Stem Cells Market was valued at USD 1535 Million in 2020 and is projected to reach USD 4756 Million by 2028, growing at a CAGR of 5.3% from 2021 to 2028.
The Global Adult Stem Cells Market was valued at USD 6.94 Billion in 2020 and is projected to reach USD 9.45 Billion by 2028, growing at a CAGR of 7.5% from 2021 to 2028.
About Us:
We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000
emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.
Contact us
Eric Kunz
6218 Georgia Avenue NW Ste 1 - 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Email: sales@vantagemarketresearch.com
Latest Vantage Market Research Press Releases @ https://www.vantagemarketresearch.com/insight/press-releases
Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs
